Cited by 58Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke ManagementParaoxonase enzyme and polymorphisms

High-density Lipoprotein Subclasses and Risk of Stroke and its Subtypes in Japanese Population: The Circulatory Risk in Communities Study

Open access
Chei, Choy-Lye, Yamagishi, Kazumasa, Kitamura, Akihiko, Kiyama, Masahiko, Imano, Hironori, Ohira, Tetsuya, Cui, Renzhe, Tanigawa, Takeshi +5 more·2013·Stroke

Abstract

Background and Purpose—: High-density lipoprotein (HDL) cholesterol is an established protective factor for ischemic stroke. However, the contribution of HDL subclasses to stroke risk and its subtypes is uncertain. Methods—: A prospective nested case–control study of 40- to 85-year-old Japanese was undertaken using frozen serum samples collected from 5280 men and 7524 women. They participated in cardiovascular risk surveys from 1985 to 1999 (1 community) and 1989 to 1998 (2 communities) under Circulatory Risk in Communities Study. HDL cholesterol subclasses were classified by high-performance liquid chromatography into 3 subgroups: S-HDL (very small or small HDL), M-HDL (medium HDL), and L-HDL (large or very large HDL) cholesterol. One control subject per case was matched by sex, age, community, serum storage year, and fasting status. Results—: In 2005, we identified 241 strokes (155 ischemic and 86 hemorrhagic). S-HDL and M-HDL cholesterol levels were inversely associated with total stroke risk, ischemic stroke, specifically lacunar infarction, and hemorrhagic stroke. After adjustment for cardiovascular risk factors, these associations remained statistically significant. Multivariable conditional odds ratios (95% confidence interval) for 1 SD (0.12 mmol/L) increment of S-HDL cholesterol levels were 0.34 (0.23–0.52) for total stroke, 0.38 (0.23–0.63) for ischemic stroke, 0.33 (0.18–0.61) for lacunar infarction, 0.30 (0.14–0.65) for hemorrhagic stroke, and 0.30 (0.12–0.77) for intraparenchymal hemorrhage. The respective multivariable odds ratios for 1SD (0.10 mmol/L) increment of M-HDL cholesterol levels were 0.56 (0.41–0.75), 0.63 (0.45–0.88), 0.59 (0.40–0.87), 0.41 (0.21–0.80), and 0.38 (0.16–0.90). No associations were found between L-HDL cholesterol levels and risk of total stroke and its subtypes. Conclusions—: Small- to medium-sized HDL, not large HDL, cholesterol levels were inversely associated with total stroke risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.112.674812

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chei, C.-L., Yamagishi, K., Kitamura, A., Kiyama, M., Imano, H., Ohira, T., Cui, R., Tanigawa, T., Sankai, T., Ishikawa, Y., Sato, S., Hitsumoto, S., & Iso, H.
Affiliations
University of Tsukuba (JP)
Venue
Stroke
Published
2013-02
Volume
44
Issue
2
Pages
327-333
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2017885282
Cited by
58
References
38
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 6 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 2 · 2015: 5 · 2014: 3 · 2013: 3
FWCI
3.61
Type
journal article
Language
en
Open access
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (19390174, 21790571)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
high-density lipoprotein subclasses, HDL cholesterol, ischemic stroke, hemorrhagic stroke, lacunar infarction, intraparenchymal hemorrhage, stroke risk, Japanese population, Circulatory Risk in Communities Study, HDL subfractions, cardiovascular risk factors, stroke subtypes, sex differences, age differences, genetic polymorphism
MeSH terms
Adult, Aged, Aged, 80 and over, Blood Circulation, Brain Ischemia, Female, Follow-Up Studies, Humans, Lipoproteins, HDL, Male, Middle Aged, Prospective Studies, Residence Characteristics, Risk Factors, Cohort Studies, Biomarkers, Case-Control Studies, Stroke, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review